Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia

Neuroscience

Volumn 78, Issue 1, 1997, Pages 99-110

  Honer, W G ^a   Falkai, P ^b   Young, C ^a   Wang, T ^a   Xie, J ^a   Bonner, J ^a   Hu, L ^a   Boulianne, G L ^c   Luo, Z ^c   Trimble, W S ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

cingulate; N CAM; schizophrenia; SNAP 25; synaptophysin; syntaxin

Indexed keywords

CELL ADHESION MOLECULE; GLUTAMIC ACID; SYNAPTOPHYSIN; SYNTAXIN;

ADULT; AGED; ARTICLE; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; NERVE ENDING; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030893368     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(96)00489-7     Document Type: Article

References (83)

1. Akbarian S., Bunney W. E., Potkin S. G., Wigal S. B., Hagman J. O., Sandman C. A. and Jones E. G. (1993) Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Archs gen. Psychiat. 50, 169-177.
2. Andreasen N. C. (1995) Symptoms, signs, and diagnosis of schizophrenia. Lancet 346, 477-481.
3. Arnold S. E., Hyman B. T., Van Hoesen G. W. and Damasio A. R. (1991) Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Archs gen. Psychiat. 48, 625-632.
4. Bailey C. H., Chen M., Keller F. and Kandel E. R. (1992) Serotonin-mediated endocytosis of apCAM: an early step of learning-related synaptic growth in Aplysia. Science 256, 645-649.
5. Barbeau D., Liang J. J., Robitaille Y., Quirion R. and Srivastava L. K. (1995) Decreased expression of the embyronic form of the nerve cell adhesion molecule in schizophrenic brains. Proc. natn. Acad. Sci. U.S.A. 92, 2785-2789.
6. Bark I. C. and Wilson M. C. (1994) Human cDNA clones encoding two different isoforms of the nerve terminal protein SNAP-25. Gene 139, 291-292.
7. Benes F. (1995) Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of the schizophrenic brain. Archs gen. Psychiat. 52, 1015-1018.
8. Benes F. M. and Bird E. D. (1987) An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Archs gen. Psychiat. 44, 608-616.
9. Benes F. M., Majocha R., Bird E. D. and Marotta C. A. (1987) Increased vertical axon numbers in cingulate cortex of schizophrenics. Archs gen. Psychiat. 44, 1017-1021.
10. Benes F. M., McSparren J., Bird E. D., Vincent S. L. and SanGiovanni J. P. (1991) Deficits in small interneurons in schizophrenic cortex. Archs gen. Psychiat. 48, 996-1001.
11. Benes F. M., Sorensen I., Vincent S. L., Bird E. D. and Sathi M. (1992) Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. Cerebral Cortex 2, 503-512.
12. A receptor binding in superficial layers of cingulate cortex in schizophrenics. J. Neurosci. 12, 924-929.
13. Bennett M. K., Calakos N. and Scheller R. H. (1992) Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science 257, 255-259.
14. Bezprozvanny I., Scheller R. H. and Tsien R. W. (1995) Functional impact of syntaxin on gating of N-type and Q-type calcium channels. Nature 378, 623-626.
15. Browning M. D., Dudek E. M., Rapier J. L., Leonard S. and Freedman R. (1993) Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol. Psychiat. 34, 529-535.
16. Cain C. C., Trimble W. S. and Lienhard G. E. (1992) Members of the VAMP family of synaptic vesicle proteins are components of glucose transporter-containing vesicles from rat adipocytes. J. biol. Chem. 267, 11681-11684.
17. Calakos N. and Scheller R. H. (1994) Protein-protein interactions contributing to the specificity of intracellular vesicular trafficking. Science 263, 1146-1149.
18. Dickson D. W., Crystal H. A., Bevona C., Honer W., Vincent I. and Davies P. (1995) Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol. Aging 16, 285-304.
19. Due C. and Catsicas S. (1995) Ultrastructural localization of SNAP-25 within the rat spinal cord and peripheral nervous system. J. comp. Neurol. 356, 152-163.
20. Eastwood S. L., Burnet P. W. J. and Harrison P. J. (1994) Striatal synaptophysin and haloperidol-induced synaptic plasticity. NeuroReport 5, 677-680.
21. Eastwood S. L., Burnet P. W. J. and Harrison P. J. (1995) Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 66, 309-319.
22. Eastwood S. L., Burnet P. W. J., McDonald B., Clinton J. and Harrison P. J. (1994) Synaptophysin gene expression in human brain: a quantitative in situ hybridization and immunocytochemical study. Neuroscience 59, 881-892.
23. Eastwood S. L. and Harrison P. J. (1995) Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience 69, 339-343.
24. Feinberg I. (1982-83) Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J. psychiat. Res. 17, 319-334.
25. Fog R., Pakkenberg H., Juul P., Bock E., Jørgensen O. S. and Andersen J. (1976) High-dose treatment of rats with perphenazine. Psychopharmacology 50, 305-307.
26. Fykse E. M., Takei K., Walch-Solimena C., Geppert M., Jahn R., De Camilli P. and Südhof T. (1993) Relative properties and localizations of synaptic vesicle protein isoforms: the case of the synaptophysins. J. Neurosci. 13, 4997-5007.
27. Gabriel S. M., Haroutunian V., Powchik P., Honer W. G., Davidson M., Davies P. and Davis K. L. (1997) Increased concentrations of presynaptic proteins in the cingulate cortex of schizophrenics. Archs gen. Psychiat. (in press).
28. Geddes G. W., Hess E. J., Hart R. A., Kesslak J. P., Cotman C. W. and Wilson M. C. (1990) Lesions of hippocampal circuitry define synaptosomal-associated protein-25 (SNAP-25) as a novel presynaptic marker. Neuroscience 38, 515-525.
29. Glantz L. A. and Lewis D. A. (1993) Synaptophysin and not rab3A is specifically reduced in the prefrontal cortex of schizophrenic subjects. Soc. Neurosci. Abstr. 20, 622.
30. Grebb J. A. and Greengard P. (1990) An analysis of synapsin II, a neuronal phosphoprotein, in postmortem brain tissue from alcoholic and neuropsychiatrically ill adults and medically ill children and young adults. Archs gen. Psychiat. 47, 1149-1156.
31. Hamos J. E., DeGennaro L. J. and Drachman D. A. (1989) Synaptic loss in Alzheimer's disease and other dementias. Neurology 39, 355-361.
32. Haracz J. L. (1984) A neural plasticity hypothesis of schizophrenia. Neurosci. Biobehav. Rev. 8, 55-71.
33. Harlow E. and Lane D. (1988) Antibodies: A Laboratory Manual, pp. 641-642. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
34. Honer W. G., Beach T. G., Hu L., Berry K., Dorovini-Zis K., Moore G. R. W. and Woodhurst B. (1994) Hippocampal synaptic pathology in patients with temporal lobe epilepsy. Acta neuropath. 87, 202-210.
35. Honer W. G., Dickson D. W., Gleeson J. and Davies P. (1992) Regional synaptic pathology in Alzheimer's disease. Neurobiol. Aging 13, 375-382.
36. Honer W. G., Hu L. and Davies P. (1993) Human synaptic proteins with a heterogeneous distribution in cerebellum and visual cortex. Brain Res. 609, 9-20.
37. Honer W. G., Kaufmann C. A. and Davies P. (1992) Characterization of a synaptic antigen of interest in neuropsychiatrie illness. Biol. Psychiat. 31, 147-158.
38. Honer W. G., Kaufmann C. A., Kleinman J. E., Casanova M. F. and Davies P. (1989) Monoclonal antibodies to study the brain in schizophrenia. Brain Res. 500, 379-383.
39. Jahn R., Schiebler W., Ouimet C. and Greengard P. (1985) A 38000-dalton membrane protein (p38) present in synaptic vesicles. Proc. natn. Acad. Sci. U.S.A. 82, 4137-4141.
40. Jakob H. and Beckmann H. (1986) Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J. neural Transm. 65, 303-326.
41. Johnston P. A., Cameron P. L., Stukenbrok H., DeCamilli P. and Südhof T. C. (1989) Synaptophysin is targeted to similar microvesicles in CHO and PC12 cells. Eur. molec. Biol. Org. J. 8, 2863-2872.
42. Jørgensen O. S. (1988) Neural cell adhesion molecule (NCAM) and prealbuminin cerebrospinal fluid from depressed patients. Acta psychiat. scand. 78 Suppl. 345, 29-37.
43. Jørgensen O. S. (1994) Nerve cell adhesion molecule in the cerebellum of weaver mutant mice. Int. J. devl Neurosci. 12, 213-225.
44. Jørgensen O. S. (1995) Nerve cell adhesion molecule (NCAM) as a quantitative marker in synaptic remodelling. Neurochem. Res. 20, 533-547.
45. Jørgensen O. S. and Stein D. C. (1992) Transplant and ganglioside G1 mediated neuronal recovery in rats with brain lesions. Res. Neurol. Neurosci. 3, 311-320.
46. Joyce J. N., Shane A., Lexow N., Winokur A., Casanova M. F. and Kleinman J. E. (1993) Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 8, 315-336.
47. Kamphuis W., Smirnova T., Hicks A., Hendriksen H., Mallet J. and Lopes da Silva F. H. (1995) The expression of syntaxin 1B/GR33 mRNA is enhanced in the hippocampal kindling model of epileptogenesis. J. Neurochem. 65, 1974-1980.
48. Koh S., Yamamoto A., Inoue A., Inoue Y., Akagawa K., Kawamura Y., Kawamoto K. and Tashiro Y. (1993) Immunoelectron microscopic localization of the HPC-1 antigen in rat cerebellum. J. Neurocytol. 22, 995-1005.
49. Loessner B., Bullock S. and Rose S. P. R. (1988) 41 IB: a monoclonal postsynaptic marker for modulations of synaptic connectivity in the rat brain. J. Neurochem. 51, 385-390.
50. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. S. (1951) Protein measurement with the Folin method. J. biol. Chem. 193, 265-275.
51. Lyons F., Martin M., Maguire C., Jackson A., Regan C. and Shelley R. (1988) The expression of an N-CAM serum fragment is positively correlated with severity of negative features in type II schizophrenia. Biol. Psychiat. 23, 769-775.
52. Masliah E., Fagan A. M., Terry R. D., DeTeresa R., Mallory M. and Gage F. H. (1991) Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP-43 in the dentate gyrus of the adult rat. Expl Neurol. 113, 131-142.
53. Masliah F., Honer W. G., Mallory M., Voight M., Kushner P., Hansen L. and Terry R. (1994) Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer's disease hippocampus. Acta neuropath. 87, 135-142.
54. Masliah E., Terry R. D., Alford M. and DeTeresa R. (1990) Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections. J. Histochem. Cytochem. 38, 837-844.
55. Masliah E., Terry R. D., DeTeresa R. M. and Hansen L. A. (1989) Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci. Lett. 103, 234-239.
56. Mayford M., Barzilai A., Keller F., Schacher S. and Kandel E. R. (1992) Modulation of an NCAM-related adhesion molecule with long-term synaptic plasticity in Aplysia. Science 256, 638-644.
57. McClain D. A. and Edelman G. M. (1982) A neural cell adhesion molecule from human brain. Proc. natn. Acad. Sci. U.S.A. 79, 6380-6384.
58. Miyakawa T., Sumiyoshi S., Deshimaru M., Suzuki T., Tomonari H., Yasuoka F. and Tatetsu S. (1972) Electron microscopic study on schizophrenia: mechanisms of pathological changes. Acta neuropath. 20, 67-77.
59. Navone F., Jahn R., Di Gioia G., Stukenbrok H., Greengard P. and De Camilli P. (1986) Protein p38: an integral membrane protein specific for small vesicles of neurons and neuroendocrine cells. J. Cell Biol. 103, 2511-2527.
60. Ong W. Y. and Garey L. J. (1993) Ultrastructural features of biopsied temporopolar cortex (area 38) in a case of schizophrenia. Schizophrenia Res. 10, 15-27.
61. Oyler G. A., Higgins G. A., Hart R. A., Battenberg E., Billingsley M., Bloom F. E. and Wilson M. C. (1989) The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations. J. Cell Biol. 109, 3039-3052.
62. Pettegrew J. W., Keshavan M. S., Panchalingam K., Strychor S., Tretta G. and Allen M. (1991) Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode schizophrenics: a pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Archs gen. Psychiat. 48, 563-568.
63. Poltorak M., Herranz A. S., Williams J., Lauretti L. and Freed W. J. (1993) Effects of frontal cortical lesions on mouse striatum: reorganization of cell recognition molecule, glial fiber, and synaptic protein expression in the dorsomedial striatum. J. Neurosci. 13, 2217-2223.
64. Poltorak M., Khoja I., Hemperly J. J., Williams J. R., El-Mallakh R. and Freed W. J. (1995) Disturbances in cell recognition molecules (N-CAM and Ll antigen) in the CSF of patients with schizophrenia. Expl Neurol. 131, 266-272.
65. Rose S. P. R. (1995) Cell-adhesion molecules, glucocorticoids and long-term-memory formation. Trends Neurosci. 18, 502-506.
66. Sesack S. R. and Snyder C. L. (1995) Cellular and subcellular localization of syntaxin-like immunoreactivity in the rat striatum and cortex. Neuroscience 67, 993-1007.
67. Silbersweig D. A., Stern E., Frith C., Cahill C., Holmes A., Grootoonk S., Seaward J., McKenna P., Chua S. E., Schnorr L., Jones T. and Frackowiak R. S. J. (1995) A functional neuroanatomy of hallucinations in schizophrenia. Nature 378, 176-179.
68. Simpson I. A., Chundu K. R., Davies-Hill T., Honer W. G. and Davies P. (1994) Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann. Neurol. 35, 546-551.
69. Smirnova T., Laroche S., Errington M. L., Hicks A. A., Bliss T. V. P. and Mallet J. (1993) Transsynaptic expression of a presyaptic glutamate receptor during hippocampal long-term potentiation. Science 262, 433-436.
70. Sower A. C., Beluc R., Bird E. D. and Perrone-Bizzizero N. I. (1994) Altered GAP-43 and synaptophysin levels in visual association cortices in schizophrenic brains. Soc. Neurosci. Abstr. 20, 621.
71. Stanley J. A., Williamson P. C., Drost D. J., Carr T. J., Rylett R. J., Malla A. and Thompson T. (1995) An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via magnetic resonance spectroscopy. Archs gen. Psychiat. 52, 399-406.
72. Stevens J. (1992) Abnormal reinnervation as a basis for schizophrenia: a hypothesis. Archs gen. Psychiat. 49, 238-243.
73. Südhof T. C., Lottspeich F., Greengard P., Mehl E. and Jahn R. (1987) The cDNA and derived amino acid sequences for rat and human synaptophysin. Nucleic Acids Res. 15, 9607.
74. Vincent S. L., Adamec E., Sorensen I. and Benes F. M. (1994) The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex. Synapse 17, 26-35.
75. Vincent S. L., McSparren J., Wang R. Y. and Benes F. M. (1991) Evidence for ultra structural changes in cortical axodendritic synapses following long-term treatment with haloperidol or clozapine. Neuropsychopharmacology 5, 147-155.
76. Waddington J. L. (1993) Schizophrenia: developmental neuroscience and pathobiology. Lancet 341, 531-536.
77. Wakabayashi K., Honer W. G. and Masliah E. (1994) Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease. Brain Res. 667, 24-32.
78. Walaas S. L, Jahn R. and Greengard P. (1988) Quantitation of nerve terminal populations: synaptic vesicle-asociated proteins as markers for synaptic density in the rat neostriatum. Synapse 2, 516-520.
79. Walch-Solimena C., Blasi J., Edelmann L., Chapman E. R., Fischer von Mollard G. and Jahn R. (1995) The t-SNAREs, syntaxin 1 and SNAP-25 are present on organelles that participate in synaptic vesicle recycling. J. Cell Biol 128, 637-645.
80. Weinberger D. R. (1995) Schizophrenia: from neuropathology to neurodevelopment. Lancet 346, 552-557.
81. r 38000 characteristic of synaptic vesicles. Cell 41, 1017-1028.
82. Wigler M., Pellicer A., Silverstein S. and Axel R. (1978) Biochemical transfer of single copy eucaryotic genes using total cellular DNA as donor. Cell 14, 725-731.
83. Zalcman S. and Endicott J. (1983) Diagnostic Evaluation After Death. Neurosciences Research Branch, National Institute of Mental Health, Washington, DC.